These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 33243194)
1. First submicroscopic inversion of the OPA1 gene identified in dominant optic atrophy - a case report. Weisschuh N; Mazzola P; Heinrich T; Haack T; Wissinger B; Tonagel F; Kelbsch C BMC Med Genet; 2020 Nov; 21(1):236. PubMed ID: 33243194 [TBL] [Abstract][Full Text] [Related]
2. The prevalence and natural history of dominant optic atrophy due to OPA1 mutations. Yu-Wai-Man P; Griffiths PG; Burke A; Sellar PW; Clarke MP; Gnanaraj L; Ah-Kine D; Hudson G; Czermin B; Taylor RW; Horvath R; Chinnery PF Ophthalmology; 2010 Aug; 117(8):1538-46, 1546.e1. PubMed ID: 20417570 [TBL] [Abstract][Full Text] [Related]
3. Genetic screening for OPA1 and OPA3 mutations in patients with suspected inherited optic neuropathies. Yu-Wai-Man P; Shankar SP; Biousse V; Miller NR; Bean LJ; Coffee B; Hegde M; Newman NJ Ophthalmology; 2011 Mar; 118(3):558-63. PubMed ID: 21036400 [TBL] [Abstract][Full Text] [Related]
4. Dominant optic atrophy caused by a novel OPA1 splice site mutation (IVS20+1G-->A) associated with intron retention. Hayashi T; Gekka T; Omoto S; Takeuchi T; Kitahara K Ophthalmic Res; 2005; 37(4):214-24. PubMed ID: 16006781 [TBL] [Abstract][Full Text] [Related]
5. Pattern of retinal ganglion cell loss in dominant optic atrophy due to OPA1 mutations. Yu-Wai-Man P; Bailie M; Atawan A; Chinnery PF; Griffiths PG Eye (Lond); 2011 May; 25(5):596-602. PubMed ID: 21378995 [TBL] [Abstract][Full Text] [Related]
6. Mutation survey of the optic atrophy 1 gene in 193 Chinese families with suspected hereditary optic neuropathy. Chen Y; Jia X; Wang P; Xiao X; Li S; Guo X; Zhang Q Mol Vis; 2013; 19():292-302. PubMed ID: 23401657 [TBL] [Abstract][Full Text] [Related]
8. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size. Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568 [TBL] [Abstract][Full Text] [Related]
9. A frameshift mutation in exon 28 of the OPA1 gene explains the high prevalence of dominant optic atrophy in the Danish population: evidence for a founder effect. Thiselton DL; Alexander C; Morris A; Brooks S; Rosenberg T; Eiberg H; Kjer B; Kjer P; Bhattacharya SS; Votruba M Hum Genet; 2001 Nov; 109(5):498-502. PubMed ID: 11735024 [TBL] [Abstract][Full Text] [Related]
10. Pure and syndromic optic atrophy explained by deep intronic OPA1 mutations and an intralocus modifier. Bonifert T; Karle KN; Tonagel F; Batra M; Wilhelm C; Theurer Y; Schoenfeld C; Kluba T; Kamenisch Y; Carelli V; Wolf J; Gonzalez MA; Speziani F; Schüle R; Züchner S; Schöls L; Wissinger B; Synofzik M Brain; 2014 Aug; 137(Pt 8):2164-77. PubMed ID: 24970096 [TBL] [Abstract][Full Text] [Related]
11. Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy. Hayashi T; Sasano H; Katagiri S; Tsunoda K; Kameya S; Nakazawa M; Iwata T; Tsuneoka H Jpn J Ophthalmol; 2017 Sep; 61(5):395-401. PubMed ID: 28668999 [TBL] [Abstract][Full Text] [Related]
12. OPA1 gene therapy prevents retinal ganglion cell loss in a Dominant Optic Atrophy mouse model. Sarzi E; Seveno M; Piro-Mégy C; Elzière L; Quilès M; Péquignot M; Müller A; Hamel CP; Lenaers G; Delettre C Sci Rep; 2018 Feb; 8(1):2468. PubMed ID: 29410463 [TBL] [Abstract][Full Text] [Related]